Showing results (21-30 of 44) with videos related to
Sort By:
Pageof 5
Obesity Research & Clinical Practice|February 8, 2024
Obesity in patients without diabetes undergoing coronary artery bypass graft surgery: Time to select patients for semaglutideNick S R Lan, Umar S Ali, Robert Larbalestier, et al.Heart, Lung & Circulation|February 6, 2013
Early postoperative bioprosthetic valve calcificationAnand Iyer, Paras Malik, Ramesh Prabha, et al.Interactive Cardiovascular and Thoracic Surgery|February 26, 2016
Sternal cables are not superior to traditional sternal wiring for preventing deep sternal wound infectionBen Dunne, Mark Murphy, Rohen Skiba, et al.Heart, Lung & Circulation|October 1, 2022
Outcomes of Cardiac Transplantation in Western Australia - A Contemporary Single Centre ExperienceUmar Ali, Lauren Giudicatti, Felicity Lee, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 5, 2023
Using machine learning to predict bleeding after cardiac surgeryVictor Hui, Edward Litton, Cyrus Edibam, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 11, 2007
VentrAssist left ventricular assist device: clinical trial results and Clinical Development Plan updateDonald Esmore, Phillip Spratt, Robert Larbalestier, et al.The Annals of Thoracic Surgery|May 24, 2015
Transapical Versus Transaortic Transcatheter Aortic Valve Implantation: A Systematic ReviewBen Dunne, Darren Tan, Daniel Chu, et al.Journal of Diabetes and Its Complications|October 6, 2021
Real-world barriers and safety of initiating sodium-glucose co-transporter 2 inhibitor treatment immediately following an acute cardiac event in people with diabetesSarah A Hitchen, Nick S R Lan, James M Rankin, et al.Journal of Lipid and Atherosclerosis|June 3, 2022
Attainment of Lipid Targets Following Coronary Artery Bypass Graft Surgery: Can We Do Better?Nick S R Lan, Umar S Ali, Bu B Yeap, et al.Internal Medicine Journal|February 3, 2022
Barriers to prescribing proprotein convertase subtilisin-kexin type 9 inhibitors after coronary revascularisationJenny Nguy, Sarah A Hitchen, Nick S R Lan, et al.Pageof 5